Intuitive Surgical (NASDAQ:ISRG) Price Target Raised to $518.00

Intuitive Surgical (NASDAQ:ISRG) had its price objective raised by BTIG Research from $494.00 to $518.00 in a research note issued to investors on Monday morning, Benzinga reports. They currently have a buy rating on the medical equipment provider’s stock.

ISRG has been the topic of a number of other research reports. Stifel Nicolaus upped their price target on Intuitive Surgical from $430.00 to $475.00 and gave the stock a “buy” rating in a research note on Friday, July 19th. Royal Bank of Canada upped their price objective on shares of Intuitive Surgical from $515.00 to $525.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 8th. JPMorgan Chase & Co. lifted their target price on shares of Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a report on Friday, October 11th. Evercore ISI increased their price target on shares of Intuitive Surgical from $410.00 to $475.00 and gave the stock an “in-line” rating in a report on Tuesday, October 1st. Finally, Truist Financial lifted their price objective on Intuitive Surgical from $520.00 to $570.00 and gave the company a “buy” rating in a report on Monday. Six analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus target price of $474.16.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock opened at $476.59 on Monday. The company has a market capitalization of $169.05 billion, a P/E ratio of 86.03, a PEG ratio of 5.40 and a beta of 1.39. Intuitive Surgical has a 1 year low of $254.85 and a 1 year high of $496.48. The company’s fifty day moving average is $482.49 and its two-hundred day moving average is $436.65.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.54 by $0.24. The firm had revenue of $2.01 billion for the quarter, compared to analyst estimates of $1.97 billion. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The business’s revenue was up 14.5% on a year-over-year basis. During the same quarter last year, the company posted $1.18 earnings per share. As a group, equities analysts expect that Intuitive Surgical will post 5.22 earnings per share for the current year.

Insider Transactions at Intuitive Surgical

In other news, Director Craig H. Barratt sold 1,400 shares of the business’s stock in a transaction on Tuesday, July 23rd. The stock was sold at an average price of $458.13, for a total value of $641,382.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, SVP Henry L. Charlton sold 40,243 shares of the firm’s stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $486.84, for a total transaction of $19,591,902.12. Following the sale, the senior vice president now owns 3,001 shares in the company, valued at approximately $1,461,006.84. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Craig H. Barratt sold 1,400 shares of the business’s stock in a transaction on Tuesday, July 23rd. The shares were sold at an average price of $458.13, for a total value of $641,382.00. The disclosure for this sale can be found here. Insiders sold a total of 53,120 shares of company stock valued at $25,528,753 in the last ninety days. Corporate insiders own 0.90% of the company’s stock.

Institutional Investors Weigh In On Intuitive Surgical

Hedge funds have recently made changes to their positions in the business. Trust Co. of Vermont lifted its position in Intuitive Surgical by 1.4% during the third quarter. Trust Co. of Vermont now owns 5,120 shares of the medical equipment provider’s stock worth $2,515,000 after buying an additional 71 shares during the period. Secure Asset Management LLC increased its stake in shares of Intuitive Surgical by 6.0% during the 3rd quarter. Secure Asset Management LLC now owns 1,534 shares of the medical equipment provider’s stock valued at $754,000 after acquiring an additional 87 shares during the last quarter. Trifecta Capital Advisors LLC lifted its holdings in shares of Intuitive Surgical by 3.1% during the 3rd quarter. Trifecta Capital Advisors LLC now owns 10,859 shares of the medical equipment provider’s stock worth $5,335,000 after acquiring an additional 330 shares during the period. Teamwork Financial Advisors LLC boosted its position in shares of Intuitive Surgical by 0.6% in the third quarter. Teamwork Financial Advisors LLC now owns 34,828 shares of the medical equipment provider’s stock worth $17,110,000 after acquiring an additional 195 shares during the last quarter. Finally, Good Life Advisors LLC grew its holdings in Intuitive Surgical by 122.4% in the third quarter. Good Life Advisors LLC now owns 10,838 shares of the medical equipment provider’s stock valued at $5,324,000 after purchasing an additional 5,964 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.